tiprankstipranks
Trending News
More News >
Fusion Antibodies Plc (GB:FAB)
:FAB
UK Market
Advertisement

Fusion Antibodies Plc (FAB) Price & Analysis

Compare
7 Followers

FAB Stock Chart & Stats


Fusion Antibodies Plc News

FAB FAQ

What was Fusion Antibodies Plc’s price range in the past 12 months?
Fusion Antibodies Plc lowest share price was 3.81p and its highest was 21.00p in the past 12 months.
    What is Fusion Antibodies Plc’s market cap?
    Fusion Antibodies Plc’s market cap is £17.33M.
      When is Fusion Antibodies Plc’s upcoming earnings report date?
      Fusion Antibodies Plc’s upcoming earnings report date is Sep 04, 2025 which is 35 days ago.
        How were Fusion Antibodies Plc’s earnings last quarter?
        Fusion Antibodies Plc released its earnings results on Nov 19, 2024. The company reported -0.008p earnings per share for the quarter, missing the consensus estimate of N/A by -0.008p.
          Is Fusion Antibodies Plc overvalued?
          According to Wall Street analysts Fusion Antibodies Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Fusion Antibodies Plc pay dividends?
            Fusion Antibodies Plc does not currently pay dividends.
            What is Fusion Antibodies Plc’s EPS estimate?
            Fusion Antibodies Plc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Fusion Antibodies Plc have?
            Fusion Antibodies Plc has 113,656,250 shares outstanding.
              What happened to Fusion Antibodies Plc’s price movement after its last earnings report?
              Fusion Antibodies Plc reported an EPS of -0.008p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.941%.
                Which hedge fund is a major shareholder of Fusion Antibodies Plc?
                Currently, no hedge funds are holding shares in GB:FAB

                Company Description

                Fusion Antibodies Plc

                Fusion Antibodies Plc (FAB) is a biotechnology company specializing in the development and production of fully human monoclonal antibodies. The company operates primarily in the life sciences sector, providing a range of services including antibody discovery, engineering, and development. Fusion Antibodies focuses on offering tailored solutions to pharmaceutical and biotechnology companies, helping them accelerate their drug discovery processes and enhance the efficacy of therapeutic antibodies.

                Fusion Antibodies Plc (FAB) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                IXICO plc
                Oxford BioDynamics
                HemoGenyx Pharmaceuticals Plc
                ValiRx plc
                Aptamer Group Plc

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis